» Articles » PMID: 12936980

Deciphering Tuberactinomycin Biosynthesis: Isolation, Sequencing, and Annotation of the Viomycin Biosynthetic Gene Cluster

Overview
Specialty Pharmacology
Date 2003 Aug 26
PMID 12936980
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

The tuberactinomycin antibiotics are essential components in the drug arsenal against Mycobacterium tuberculosis infections and are specifically used for the treatment of multidrug-resistant tuberculosis. These antibiotics are also being investigated for their targeting of the catalytic RNAs involved in viral replication and for the treatment of bacterial infections caused by methicillin-resistant Staphylococcus aureus strains and vancomycin-resistant enterococci. We report on the isolation, sequencing, and annotation of the biosynthetic gene cluster for one member of this antibiotic family, viomycin, from Streptomyces sp. strain ATCC 11861. This is the first gene cluster for a member of the tuberactinomycin family of antibiotics sequenced, and the information gained can be extrapolated to all members of this family. The gene cluster covers 36.3 kb of DNA and encodes 20 open reading frames that we propose are involved in the biosynthesis, regulation, export, and activation of viomycin, in addition to self-resistance to the antibiotic. These results enable us to predict the metabolic logic of tuberactinomycin production and begin steps toward the combinatorial biosynthesis of these antibiotics to complement existing chemical modification techniques to produce novel tuberactinomycin derivatives.

Citing Articles

Integrated genome and metabolome mining unveiled structure and biosynthesis of novel lipopeptides from a deep-sea Rhodococcus.

Ragozzino C, Palma Esposito F, Buonocore C, Tedesco P, Coppola D, Paccagnella D Microb Biotechnol. 2024; 17(11):e70011.

PMID: 39582288 PMC: 11586506. DOI: 10.1111/1751-7915.70011.


Catalytic divergencies in the mechanism of L-arginine hydroxylating nonheme iron enzymes.

Ali H, de Visser S Front Chem. 2024; 12:1365494.

PMID: 38406558 PMC: 10884159. DOI: 10.3389/fchem.2024.1365494.


Discovery and characterization of genes conferring natural resistance to the antituberculosis antibiotic capreomycin.

Toh S, Elaine Keisha J, Wang Y, Pan Y, Jhu Y, Hsiao P Commun Biol. 2023; 6(1):1282.

PMID: 38114770 PMC: 10730852. DOI: 10.1038/s42003-023-05681-6.


Dehydroamino acid residues in bioactive natural products.

Wang S, Wu K, Tang Y, Deng H Nat Prod Rep. 2023; 41(2):273-297.

PMID: 37942836 PMC: 10880069. DOI: 10.1039/d3np00041a.


Complete sequences of conjugal helper plasmids pRK2013 and pEVS104.

Hall A, Donohue T, Peters J MicroPubl Biol. 2023; 2023.

PMID: 37521139 PMC: 10375283. DOI: 10.17912/micropub.biology.000882.


References
1.
Tiffany K, Roberts D, Wang M, Paschke R, Mohsen A, Vockley J . Structure of human isovaleryl-CoA dehydrogenase at 2.6 A resolution: structural basis for substrate specificity,. Biochemistry. 1997; 36(28):8455-64. DOI: 10.1021/bi970422u. View

2.
Marahiel M, Stachelhaus T, Mootz H . Modular Peptide Synthetases Involved in Nonribosomal Peptide Synthesis. Chem Rev. 2002; 97(7):2651-2674. DOI: 10.1021/cr960029e. View

3.
Murray C, Salomon J . Modeling the impact of global tuberculosis control strategies. Proc Natl Acad Sci U S A. 1998; 95(23):13881-6. PMC: 24946. DOI: 10.1073/pnas.95.23.13881. View

4.
Townsend C . New reactions in clavulanic acid biosynthesis. Curr Opin Chem Biol. 2002; 6(5):583-9. DOI: 10.1016/s1367-5931(02)00392-7. View

5.
Jenne A, Hartig J, Piganeau N, Tauer A, Samarsky D, Green M . Rapid identification and characterization of hammerhead-ribozyme inhibitors using fluorescence-based technology. Nat Biotechnol. 2001; 19(1):56-61. DOI: 10.1038/83513. View